SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-069645
Filing Date
2009-03-31
Accepted
2009-03-31 17:27:10
Documents
6
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1136479
2 CONSENT OF BDO SEIDMAN, LLP dex231.htm EX-23.1 3031
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF JAMES M. FRINCKE dex311.htm EX-31.1 10078
4 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF ROBERT W. WEBER dex312.htm EX-31.2 10278
5 SECTION 1350 CERTIFICATIONS OF JAMES M. FRINCKE AND ROBERT W. WEBER dex321.htm EX-32.1 6704
6 GRAPHIC g70481g45l47.jpg GRAPHIC 50687
  Complete submission text file 0001193125-09-069645.txt   1238097
Mailing Address 4435 EASTGATE MALL SUITE 400 SAN DIEGO CA 92121
Business Address 4435 EASTGATE MALL SUITE 400 SAN DIEGO CA 92121 858-587-9333
HOLLIS EDEN PHARMACEUTICALS INC /DE/ (Filer) CIK: 0000899394 (see all company filings)

IRS No.: 133697002 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24672 | Film No.: 09720465
SIC: 2834 Pharmaceutical Preparations